|
RGPD6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.338200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.148000E-02 |
| Normal-vs-Stage2 |
9.815400E-01 |
| Normal-vs-Stage3 |
5.831400E-01 |
| Normal-vs-Stage4 |
9.748800E-01 |
| Stage1-vs-Stage2 |
3.829600E-01 |
| Stage1-vs-Stage3 |
4.231600E-01 |
| Stage1-vs-Stage4 |
3.195000E-01 |
| Stage2-vs-Stage3 |
7.380200E-01 |
| Stage2-vs-Stage4 |
9.684400E-01 |
| Stage3-vs-Stage4 |
7.366200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.906000E-02 |
| Normal-vs-AfricanAmerican |
2.845600E-01 |
| Normal-vs-Asian |
3.594200E-01 |
| Caucasian-vs-AfricanAmerican |
7.412600E-01 |
| Caucasian-vs-Asian |
9.323600E-02 |
| AfricanAmerican-vs-Asian |
1.782170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.536200E-03 |
| Normal-vs-Female |
2.841400E-01 |
| Male-vs-Female |
1.521650E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.387000E-01 |
| Normal-vs-Extreme_Weight |
3.278900E-03 |
| Normal-vs-Obese |
5.001200E-01 |
| Normal-vs-Extreme_Obese |
7.238400E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.161000E-01 |
| Normal_Weight-vs-Obese |
8.253800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.282780E-01 |
| Extreme_Weight-vs-Obese |
6.273600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.197400E-01 |
| Obese-vs-Extreme_Obese |
3.887800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.155700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.439400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.336900E-03 |
| Normal-vs-Age(81-100Yrs) |
4.405900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.388400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.280500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.442400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.023900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.499800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.654200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.350000E-02 |
| Normal-VS-Type2 PRCC |
2.595400E-04 |
| Normal-VS-KIRP CIMP |
2.543200E-03 |
| Normal-VS-Unclassified PRCC |
9.193200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.470060E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.09060002432216E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
1.750850E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.43479994552109E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
7.139500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.197900E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.780300E-03 |
| Normal-vs-N1 |
3.218000E-01 |
| Normal-vs-N2 |
2.583400E-01 |
| N0-vs-N1 |
1.083750E-02 |
| N0-vs-N2 |
7.075000E-01 |
| N1-vs-N2 |
3.522200E-01 |
|
|
